WallStreetZenWallStreetZen

NASDAQ: VRCA
Verrica Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Verrica Pharmaceuticals earnings were -$48.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VRCA earnings report on Jun 30, 2025 announced Q2 2025 earnings of $204.0k, down 102.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRCA reported annual earnings of -$76.6M, with 14.3% growth. The next VRCA earnings date is Nov 10, 2025.

VRCA earnings history

Current Revenue
$14.7M
Current Earnings
-$48.6M
Current Profit Margin
-330.5%

VRCA Return on Equity

Current Company
N/A
Current Industry
-10%
Current Market
30.7%

VRCA undefined

Current Company
-115.5%
Current Industry
-0.2%
VRCA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VRCA announces earnings.

VRCA undefined

Current Company
-400.01%
Current Industry
6.4%
VRCA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRCA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VRCA-$38.54M-$48.60MN/A-$7.68
BRNS-$60.10M-$69.43MN/A-$1.73
PSTV-$14.57M-$19.03MN/A-$2.03
BTAI-$34.61M-$50.95MN/A-$11.94
CALC-$20.05M-$20.87MN/A-$1.60
View Top Biotech Stocks

VRCA earnings dates

Next earnings date
Nov 10, 2025

Verrica Pharmaceuticals Earnings Reports & History FAQ

What were Verrica Pharmaceuticals's earnings last quarter?

On VRCA's earnings call on Invalid Date, Verrica Pharmaceuticals (NASDAQ: VRCA) reported Q2 2025 earnings per share (EPS) of $0.02, up 100.54% year over year. Total VRCA earnings for the quarter were $204.00 thousand. In the same quarter last year, Verrica Pharmaceuticals's earnings per share (EPS) was -$3.70.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.

When does Verrica Pharmaceuticals report earnings?

The next VRCA earnings call is Invalid Date. Add VRCA to your watchlist to be reminded of Verrica Pharmaceuticals's next earnings date.

Is Verrica Pharmaceuticals profitable or losing money?

As of the last Verrica Pharmaceuticals earnings report, Verrica Pharmaceuticals is currently losing money. Verrica Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$48.60 million, a 44.09% decrease year over year.

What was VRCA's earnings growth in the past year?

As of Verrica Pharmaceuticals's earnings date in Invalid Date, Verrica Pharmaceuticals's earnings has grown year over year. VRCA earnings in the past year totalled -$48.60 million.

What are Verrica Pharmaceuticals's earnings expectations?

The current EPS estimate for Verrica Pharmaceuticals's earnings report in Invalid Date is -$0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.